Target intelligence / Profile preview

Ankyrin repeat domain-containing protein 30B-like (ANKRD30BL)

Target
ANKRD30BL
Molecular classification
Other (Ankyrin repeat domain-containing protein)
01

Overview

Ankyrin repeat domain-containing protein 30B-like (ANKRD30BL) is a member of the ankyrin repeat domain-containing protein family, characterized by the presence of ankyrin repeats, which are known protein–protein interaction motifs[1][3]. ANKRD30BL is expressed in various human tissues, but its precise molecular function remains undetermined. Studies have indicated that the ANKRD30BL transcript is significantly enriched in tissues affected by chronic periodontitis, suggesting involvement in inflammatory and potentially oncogenic processes, possibly through pathways that govern cell cycle progression, apoptosis, or responses to cellular stress[1][3]. Because of the broad roles of ankyrin repeat domains in mediating interactions and regulatory processes, ANKRD30BL may act as a regulator or adaptor within certain signaling pathways, but experimental confirmation is needed. Currently, no evidence specifically designates ANKRD30BL as a therapeutic target, nor are there known drugs that interact with it or established uses in biomarker or safety contexts.

Other names
NCRNA00164ANKRD30BP3ankyrin repeat domain 30B-likeputative ankyrin repeat domain-containing protein 30B-likeankyrin repeat domain 30B pseudogene 3
02

Biological functions

Cell proliferationCell differentiationProtein-protein interactionOther (precise biological functions are not fully elucidated)
03

Disease associations

Other (implicated in chronic periodontitis and potentially in oncogenic processes, but specific disease roles are not firmly established)

Beyond the preview

Go deeper on Ankyrin repeat domain-containing protein 30B-like (ANKRD30BL).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ankyrin repeat domain-containing protein 30B-like (ANKRD30BL).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call